ASST vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

ASST

45.1
AI Score
VS
CNS Wins

CNS

57.5
AI Score

Investment Advisor Scores

ASST

45score
Recommendation
HOLD

CNS

58score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASST CNS Winner
Forward P/E 5.5006 18.4502 ASST
PEG Ratio 0 1.6881 Tie
Revenue Growth 94.6% 12.2% ASST
Earnings Growth 0.0% 31.9% CNS
Tradestie Score 45.1/100 57.5/100 CNS
Profit Margin 0.0% 28.8% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY CNS

Relative Price Performance (Last 90 Days)

ASST 1M: +0.1% · 3M: +152.7% CNS 1M: -4.5% · 3M: -11.4%

Current Technical Phase

ASST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.0% over 20 days), RSI 56

RSI (14): 56.2 · Price: $29.03

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.0 · Price: $72.07

Fundamentals Snapshot

Metric ASST CNS
Market Cap — —
Forward P/E -30.2 19.3
Trailing P/E — 21.6
Revenue (TTM) — —
Revenue Growth 0.9% 0.1%
Gross Margin -6.0% 0.5%
Operating Margin -84.8% 0.3%
EPS -204.80 3.25
Dividend Yield — 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.